Christopher Ryan Gress, CF-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 200 Nat Washington Way, Ephrata, WA 98823 Phone: 509-754-4631 |
News Archive
Flexion Therapeutics, Inc. today reported that its lead osteoarthritis drug candidate, FX005, demonstrated significant pain relief over placebo at four weeks in a Phase 2 proof-of-concept trial. Top-line data showed FX005, delivered intra-articularly to the knee, was well-tolerated and resulted in prolonged improvement in joint pain and function throughout the 12-week duration of the study.
A team of scientists at the Population Health Research Institute, Hamilton Health Sciences, and McMaster University, Hamilton, in Ontario, Canada, revealed that increased plasma ACE2 levels in the blood could indicate a higher risk of major cardiovascular events. The study is published in the journal The Lancet.
MRI shows changes in the brains of people with post-concussion syndrome (PCS), according to a new study published online in the journal Radiology. Researchers hope the results point the way to improved detection and treatment for the disorder.
Women who have never smoked but are exposed to smoking in the home for more than 30 years are at an increased risk of developing lung cancer compared with women without this passive smoking exposure, suggest researchers.
› Verified 2 days ago